Found: 31
Select item for more details and to access through your institution.
A phase 1 trial of SGN-CD70A in patients with CD70-positive, metastatic renal cell carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Phase I dose-escalation study of SGN-75 in patients with CD70-positive relapsed/refractory non-Hodgkin lymphoma or metastatic renal cell carcinoma.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 6, p. 1246, doi. 10.1007/s10637-014-0151-0
- By:
- Publication type:
- Article
Bendamustine in Non-Hodgkin Lymphoma: The Double-Agent that Came from the Cold War.
- Published in:
- Clinical Lymphoma & Myeloma, 2007, v. 8, p. S13
- By:
- Publication type:
- Article
Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast Cancer.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 12, p. e2349646, doi. 10.1001/jamanetworkopen.2023.49646
- By:
- Publication type:
- Article
A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 198, n. 2, p. 217, doi. 10.1007/s10549-023-06864-9
- By:
- Publication type:
- Article
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 167, n. 3, p. 671, doi. 10.1007/s10549-017-4537-5
- By:
- Publication type:
- Article
Phase 1 Study Evaluating Pharmacokinetics and Tolerability of Ofatumumab Combined With Bendamustine in Patients With Indolent B‐Cell Non‐Hodgkin's Lymphoma.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 9, p. 1099, doi. 10.1002/cpdd.1133
- By:
- Publication type:
- Article
TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Development and Integration of Antibody–Drug Conjugate in Non-Hodgkin Lymphoma.
- Published in:
- Current Oncology Reports, 2015, v. 17, n. 9, p. 41, doi. 10.1007/s11912-015-0466-9
- By:
- Publication type:
- Article
A Phase II study of SGN-30 (anti-CD30 mAb) in Hodgkin lymphoma or systemic anaplastic large cell lymphoma.
- Published in:
- British Journal of Haematology, 2009, v. 146, n. 2, p. 171, doi. 10.1111/j.1365-2141.2009.07740.x
- By:
- Publication type:
- Article
What Is Important When Making Treatment Decisions in Metastatic Breast Cancer? A Qualitative Analysis of Decision‐Making in Patients and Oncologists.
- Published in:
- Oncologist, 2019, v. 24, n. 10, p. 1313, doi. 10.1634/theoncologist.2018-0711
- By:
- Publication type:
- Article
Brentuximab Vedotin in Transplant-Naïve Patients with Relapsed or Refractory Hodgkin Lymphoma: Analysis of Two Phase I Studies.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Brentuximab Vedotin in Transplant-Naïve Patients with Relapsed or Refractory Hodgkin Lymphoma: Analysis of Two Phase I Studies.
- Published in:
- Oncologist, 2012, v. 17, n. 8, p. 1073, doi. 10.1634/theoncologist.2012-0133
- By:
- Publication type:
- Article
Concomitant imatinib and ibrutinib in a patient with chronic myelogenous leukemia and chronic lymphocytic leukemia.
- Published in:
- Clinical Case Reports, 2017, v. 5, n. 6, p. 899, doi. 10.1002/ccr3.974
- By:
- Publication type:
- Article
An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Three‐year outcomes with brentuximab vedotin plus bendamustine as first salvage therapy in relapsed or refractory Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 3, p. e86, doi. 10.1111/bjh.16499
- By:
- Publication type:
- Article
An open‐label phase 2 trial of entospletinib in indolent non‐Hodgkin lymphoma and mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 2, p. 215, doi. 10.1111/bjh.15552
- By:
- Publication type:
- Article
Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2<sup>+</sup> breast cancer in the adaptively randomized I-SPY2 trial.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26019-y
- By:
- Publication type:
- Article
CD40 Pathway Activation Status Predicts Response to CD40 Therapy in Diffuse Large B Cell Lymphoma.
- Published in:
- Science Translational Medicine, 2011, v. 3, n. 74, p. 1, doi. 10.1126/scitranslmed.3001620
- By:
- Publication type:
- Article
Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer ("METRIC"): a randomized multicenter study.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00244-6
- By:
- Publication type:
- Article
PIK3CA and MAP3K1 alterations imply luminal A status and are associated with clinical benefit from pan-PI3K inhibitor buparlisib and letrozole in ER+ metastatic breast cancer.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0126-6
- By:
- Publication type:
- Article
Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans.
- Published in:
- PLoS ONE, 2017, v. 12, n. 9, p. 1, doi. 10.1371/journal.pone.0183832
- By:
- Publication type:
- Article
How do I treat "triple-negative" disease.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Basal-like breast cancer stem cells are sensitive to anti-DR5 mediated cytotoxicity.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 133, n. 2, p. 437, doi. 10.1007/s10549-011-1763-0
- By:
- Publication type:
- Article
A Phase Ib study of ruxolitinib + gemcitabine ± nab-paclitaxel in patients with advanced solid tumors.
- Published in:
- OncoTargets & Therapy, 2018, v. 11, p. 2399, doi. 10.2147/OTT.S157331
- By:
- Publication type:
- Article
Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00493-z
- By:
- Publication type:
- Article
Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00337-2
- By:
- Publication type:
- Article
Pilot trial of preoperative (neoadjuvant) letrozole in combination with bevacizumab in postmenopausal women with newly diagnosed estrogen receptor- or progesterone receptor-positive breast cancer.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Pilot Trial of Preoperative (Neoadjuvant) Letrozole in Combination With Bevacizumab in Postmenopausal Women With Newly Diagnosed Estrogen Receptor– or Progesterone Receptor–Positive Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 4, p. 275, doi. 10.3816/CBC.2010.n.035
- By:
- Publication type:
- Article
A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors.
- Published in:
- Journal of Hematology & Oncology, 2014, v. 7, n. 1, p. 3, doi. 10.1186/1756-8722-7-44
- By:
- Publication type:
- Article
Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies.
- Published in:
- Journal of Hematology & Oncology, 2014, v. 7, n. 1, p. 1, doi. 10.1186/1756-8722-7-24
- By:
- Publication type:
- Article